http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleInterno/MATRICOLA29566
MELCHIORRE CERVELLO
- Type
- Label
- MELCHIORRE CERVELLO (literal)
- MELCHIORRE CERVELLO (literal)
- Subject
- Gestore di
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Synthesis and characterization of polyaminoacidic polycations for gene delivery. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Advances in targeting signal transduction pathways. (Articolo in rivista) (Prodotto della ricerca)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (Prodotto della ricerca)
- Non invasive tools for the diagnosis of liver cirrhosis (Articolo in rivista) (Prodotto della ricerca)
- Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The tumor microenvironment in hepatocellular carcinoma (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the cancer initiating cell: the ultimate target for cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Correlation between expression of cyclooxygenase-2 and presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Management of liver failure: from transplantation to cell-based therapy. (Articolo in rivista) (Prodotto della ricerca)
- Expression of the IAPs in multidrug resistant tumor cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Development of nimesulide loaded solid lipid nanoparticles. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cloning and expression of a type IX-like collagen in tissues of the ascidian Ciona intestinalis. (Articolo in rivista) (Prodotto della ricerca)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Nanoparticelle lipidiche solide cationiche come vettori del DNA. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Gamma enolase expression as early marker of neuronal differentiation of murine neuroblastoma cells N-115 (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Role of the PI3K/PTEN/AKT/mTOR pathway in breast cancer drug resistance and sensitivity to targeted therapy. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Nanoparticelle lipidiche solide cationiche come vettori del DNA. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- Romancino DP., Dalmazio S., Cervello M., Montana G., Virruso L., Bonura A., Gambino R. and Di Carlo M. Localization and association to cytoskeleton of COLL1a mRNA in Paracentrotus lividus egg requires cis- and trans-acting factors (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- GSK-3beta is a critical mediator of tetrandrine induced cell cycle arrest and cytotoxicity. (Articolo in rivista) (Prodotto della ricerca)
- Transcriptional regulation of signature miRNAs. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Role of the PI3K/PTEN/AKT/mTOR pathway in breast cancer drug resistance and sensitivity to targeted therapy. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Suppressing prostate cancer by targeting NGAL (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (Prodotto della ricerca)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Contributo in atti di convegno) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Contributo in atti di convegno) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Sex hormones and risk of liver tumors (Contributo in atti di convegno) (Prodotto della ricerca)
- Solid-lipid nanoparticles for gene delivery to cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production. (Contributo in atti di convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Emerging MEK inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) (Articolo in rivista) (Prodotto della ricerca)
- Akt as a Therapeutic Target in Cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cyclooxygenases in hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- IAPs: looking for their pharmacological inhibition in hepatocellular carcinoma cells. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Expression of the IAPs (Inhibitory of Apoptosis Proteins) in drug resistant tumor cells. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Expression of HIP/PAP mrna in human hepatoma cell lines (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effects on inhibitor of apoptosis protein levels (Articolo in rivista) (Prodotto della ricerca)
- Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production (Abstract/Poster in convegno) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Epidemiology, risk factors, and natural history of hepatocellular carcinoma (Articolo in rivista) (Prodotto della ricerca)
- Circulating IL-6 and sil-6R in patients with hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- IL-6 -174G®C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Drug resistance, signaling pathways: roles for in cancer stem cells? (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Association between single nucleotide polymorphisms in the COX-2, TNF-± and VEGF-A genes, and susceptibility to hepatocellular carcinoma (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Nanotechnology applications for the therapy of liver fibrosis (Articolo in rivista) (Prodotto della ricerca)
- IAPs as new possibile pharmacological targets in hepatocellular cancer. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Correlation of cyclooxygenase-2 expression with the presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- The proteasome inhibitor MG132 induces apoptosis in human hepatocellular carcinoma cells: involvement of caspase-dependent cleavage of beta-catenin. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Roles of proliferative and metastatic pathways in chemotherapeutic drug resistance and cancer stem cells-sites for therapeutic intervention (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Cyclooxygenase-2, Tumor Necrosis Factor-±, Vascular Endothelial Growth factor-A and IL-6 genes SNPS and Il-6 serum levels in liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Correlation between neutrofil associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) levels in hepatocellular carcinoma development. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Targeting cancer stem cells - Lancing their Achilles heel. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Inhibition of cell growth in human hepatocellular carcinoma cells by selective COX-2 inhibitors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Abstract/Poster in convegno) (Prodotto della ricerca)
- Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- IP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukemia cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Sex hormones and risk of liver tumors (Abstract/Poster in convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. (Articolo in rivista) (Prodotto della ricerca)
- Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cyclooxygenases in cancer (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- Targeting the Raf/MEK/ERK pathway with small molecule inhibitors (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION (Abstract in rivista) (Prodotto della ricerca)
- Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Transcriptional regulation of miR-224 upregulated in human HCCs by NFkB inflammatory pathways. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Emerging Raf inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. (Articolo in rivista) (Prodotto della ricerca)
- Phosphorylation-dependent regulation of axon fasciculation. (Articolo in rivista) (Prodotto della ricerca)
- Phosphorylation-dependent regulation of skeletogenesis in sea urchin micromere-derived cells and embryos. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Spontaneous cytotoxic activity of eosinophilic granule cells separated from the normal peritoneal cavity of Dicentrarchus labrax. (Articolo in rivista) (Prodotto della ricerca)
- Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Transcriptional regulation of signature miRNAs (Contributo in atti di convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (Prodotto della ricerca)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Contributo in atti di convegno) (Prodotto della ricerca)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Contributo in atti di convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Corrigendum to \"Poly (ADP-ribose) polymerase inhibition synergizes with the NF-?B inhibitor DHMEQ to kill hepatocellular carcinoma cells\" [Biochim. Biophys. Acta 1843 (2014) 2662-2673] (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- GSK-3 as potential target for therapeutic irvention in cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Diverse roles of GSK-3: Tumor promoter-tumor suppressor, target in cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- Spatial distribution of collagene TypeI mRNA in Paracentrotus lividus eggs and embryos. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting signaling pathways in prostate cancer (Abstract/Comunicazione in rivista) (Prodotto della ricerca)
- New Agents and Approaches for Targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR Cell Survival Pathways (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- Cationic solid-lipid nanoparticles for gene delivery. (Contributo in atti di convegno) (Prodotto della ricerca)
- Coautore
- Responsabile di
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
Incoming links:
- Autore CNR
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression. (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production. (Contributo in atti di convegno) (Prodotto della ricerca)
- Sex hormones and risk of liver tumors (Contributo in atti di convegno) (Prodotto della ricerca)
- Solid-lipid nanoparticles for gene delivery to cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Contributo in atti di convegno) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Contributo in atti di convegno) (Prodotto della ricerca)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Contributo in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Nanoparticelle lipidiche solide cationiche come vettori del DNA. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Microgravity and cellular homeostasis:effects of stimulated hypogravity on FRTL-5 thyroid cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Role of the PI3K/PTEN/AKT/mTOR pathway in breast cancer drug resistance and sensitivity to targeted therapy. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Cloning and expression of a type IX-like collagen in tissues of the ascidian Ciona intestinalis. (Articolo in rivista) (Prodotto della ricerca)
- Downregulation of wild-type beta-catenin expression by interleukin 6 in human hepatocarcinoma HepG2 cells: a possible role in the growth-regulatory effects of the cytokine? (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Synthesis and characterization of polyaminoacidic polycations for gene delivery. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of the IAPs in multidrug resistant tumor cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of beta-catenin and inhibition of beta-catenin-mediated transactivation (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Correlation between expression of cyclooxygenase-2 and presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of IAPs and alternative splice variants in hepatocellular carcinoma tissues and cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Aromatase and amphiregulin are correspondingly expressed in human liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Akt as a Therapeutic Target in Cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel combination of celecoxib and proteasome inhibitor MG132 provides synergistic antiproliferative and proapoptotic effects in human liver tumor cells. Cell Cycle. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Emerging MEK inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- IL-6 -174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- COX-2-Dependent and COX-2-Independent Mode of Action of Celecoxib in Human Liver Cancer Cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins) (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (Prodotto della ricerca)
- Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma (Articolo in rivista) (Prodotto della ricerca)
- Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possible relationship to the effects on inhibitor of apoptosis protein levels (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenases in hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Induction of apoptosis and inhibition of cells growth in human hepatocellular carcinoma cells by COX-2 inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- GSK-3beta is a critical mediator of tetrandrine induced cell cycle arrest and cytotoxicity. (Articolo in rivista) (Prodotto della ricerca)
- Circulating E-selectin levels in chronic hepatitis C patients with normal or elevated transaminase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- Association between single nucleotide polymorphisms in the cyclooxygenase-2, tumor necrosis factor-±, and vascular endothelial growth factor-A genes, and susceptibility to hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Expression of HIP/PAP mrna in human hepatoma cell lines (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Circulating IL-6 and sil-6R in patients with hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Epidemiology, risk factors, and natural history of hepatocellular carcinoma (Articolo in rivista) (Prodotto della ricerca)
- Circulating intercellular adhesion molecule-1 in chronic hepatitis C patients with normal or elevated aminotransferase before and after alpha-interferon treatment. (Articolo in rivista) (Prodotto della ricerca)
- Response to antiviral therapy and hepatic expression of cyclooxygenases in chronic hepatitis C (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the Raf/MEK/ERK pathway with small molecule inhibitors (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Sex hormones and risk of liver tumor. (Articolo in rivista) (Prodotto della ricerca)
- Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies. (Articolo in rivista) (Prodotto della ricerca)
- Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Articolo in rivista) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver diseases and hepatocellular carcinoma: an immunohistochemical study . (Articolo in rivista) (Prodotto della ricerca)
- Antitumor effects of DHMEQ, a novel NF-kB inhibitor, in human liver cancer cells is mediated through a reactive oxygen species-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Emerging Raf inhibitors. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. (Articolo in rivista) (Prodotto della ricerca)
- Management of liver failure: from transplantation to cell-based therapy. (Articolo in rivista) (Prodotto della ricerca)
- Solid lipid nanoparticles (SLNs) containing nimesulide: preparation, characterization and in cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Contributo in atti di convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Contributo in atti di convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells. (Contributo in atti di convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Contributo in atti di convegno) (Prodotto della ricerca)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Contributo in atti di convegno) (Prodotto della ricerca)
- Transcriptional regulation of signature miRNAs (Contributo in atti di convegno) (Prodotto della ricerca)
- Inhibition of cell growth in human hepatocellular carcinoma cells by selective COX-2 inhibitors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Potentiation of antitumor effects of NSAIDs by inhibition of MEK/ERK activity in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the selective cyclooxygenase-1 inhibitor SC-560 is potentiated by inhibiton of MEK/ERK pathway in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combine with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production (Abstract/Poster in convegno) (Prodotto della ricerca)
- Growth suppression and apoptosis induction in human hepatoma cells by DHMEQ, a novel NF-KB inhibitor, is mediated through a ROS-dependent mechanism. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Drug resistance, signaling pathways: roles for in cancer stem cells? (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Association between single nucleotide polymorphisms in the COX-2, TNF-± and VEGF-A genes, and susceptibility to hepatocellular carcinoma (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- IL-6 -174G®C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Frequent alteration of the Yin Yang/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- The novel NF-kB inhibitor DHMEQ suppresses the growth of human hepatic cancer cells through redox-dependent signaling. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- DHMEQ and Celecoxib synergistically exert anti-tumoral activities in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of DHMEQ and Celecoxib synergistically exert anti-tumoral effects in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- The multikinase inhibitor Sorafenib exhibits a strong cytotoxic effect in liver cancer cells through a MEK/ERK signaling-independent mechanism (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Expression of the IAPs (Inhibitory of Apoptosis Proteins) in drug resistant tumor cells. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- IAPs: looking for their pharmacological inhibition in hepatocellular carcinoma cells. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Antitumor effects of curcumin and its combination with cisplatin or doxorubicin on hepatic cancer cells: possible relationship to NF-kB activation and IAP gne expression (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- The selective COX-1 inhibitor SC-560 suppresses cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Nanoparticelle lipidiche solide cationiche come vettori del DNA. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Microgravity and cellular homeostasis: effects of simulated hypogravity on FRTL-5 thyroid cells. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- G. Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Role of the PI3K/PTEN/AKT/mTOR pathway in breast cancer drug resistance and sensitivity to targeted therapy. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Transcriptional regulation of micro-RNAs highly expressed in human HCCS (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Hepatic expression of cycloxygenase-2 in non-alcoholic fatty liver disease. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Transcriptional regulation of signature miRNAs. (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Correlation between neutrofil associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) levels in hepatocellular carcinoma development. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Targeting cancer stem cells - Lancing their Achilles heel. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Roles of proliferative and metastatic pathways in chemotherapeutic drug resistance and cancer stem cells-sites for therapeutic intervention (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Cyclooxygenase-2, Tumor Necrosis Factor-±, Vascular Endothelial Growth factor-A and IL-6 genes SNPS and Il-6 serum levels in liver cirrhosis and hepatocellular carcinoma. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Cyclooxygenases in cancer (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- The proteasome inhibitor MG132 induces apoptosis in human hepatocellular carcinoma cells: involvement of caspase-dependent cleavage of beta-catenin. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- IAPs as new possibile pharmacological targets in hepatocellular cancer. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Correlation of cyclooxygenase-2 expression with the presence of inflammatory cells in human primary hepatocellular carcinoma: a possible role in tumor promotion and angiogenesis. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Sex hormones and risk of liver tumors (Abstract/Poster in convegno) (Prodotto della ricerca)
- Significance of autologous Interleukin 6 production in the HA22T/VGH cell model of hepatocellular carcinoma. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Inhibition of MEK/ERK pathway enhances apoptosis induced by selective COX-1 and COX-2 inhibitors in human hepatocellular carcinoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cationic Solid-lipid nanoparticles as DNA carriers. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Influence of MEK/ERK signaling on apoptosis induced by selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatocellular carcinoma cells (Abstract/Poster in convegno) (Prodotto della ricerca)
- Cyclooxygenase-2 expression in chronic liver disease and hepatocellular carcinoma: an immunohistochemical study. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Aromatase and amphiregulin are correspondingly espressed in human liver cancer cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Combination of the selective COX-2 inhibitor Celecoxib and the proteasome inibitor MG132 synergistically induces anti-proliferative and pro-apoptotic activity in liver cancer cells: possible involvement of endoplasmic reticulum stress response. (Abstract/Poster in convegno) (Prodotto della ricerca)
- DHMEQ, a novel NF-kb inhibitor, anticancer activity through induction of reactive oxygen species-dependent mechanism in human hepatoma cells. (Abstract/Poster in convegno) (Prodotto della ricerca)
- Micro-RNA signature of human hepatocellular carcinoma (HCC). (Abstract/Poster in convegno) (Prodotto della ricerca)
- Gene expression profiling of human liver cancer cells following celecoxib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Altered gene expression profiles in liver cancer cells upon sorafenib treatment. (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cationic solid-lipid nanoparticles for gene delivery. (Contributo in atti di convegno) (Prodotto della ricerca)
- Nanostructured lipid carriers-containing anticancer compounds: preparation, characterization, and cytotoxicity studies (Articolo in rivista) (Prodotto della ricerca)
- Targeting the cancer initiating cell: the ultimate target for cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The tumor microenvironment in hepatocellular carcinoma (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Combination treatment with celecoxib and DHMEQ or curcumin results in synergistic cell growth inhibition in hepatic cancer cells (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health (Articolo in rivista) (Prodotto della ricerca)
- Novel cationic solid-lipid nanoparticles as non-viral vectors for gene delivery (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Molecular mechanisms of sorafenib action in liver cancer cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antitumor effects of the novel NF-kappa B inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: Analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production (Articolo in rivista) (Prodotto della ricerca)
- Transcriptional regulation of miR-224 upregulated in human HCCs by NFkB inflammatory pathways. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- The novel NF-kB inhibitor DHMEQ synergizes with celecoxib to exert antitumor effects on human liver cancer cells by a ROS-dependent mechanism. (Articolo in rivista) (Prodotto della ricerca)
- Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. (Articolo in rivista) (Prodotto della ricerca)
- Advances in targeting signal transduction pathways. (Articolo in rivista) (Prodotto della ricerca)
- New Agents and Approaches for Targeting the RAS/RAF/MEK/ERK and PI3K/AKT/mTOR Cell Survival Pathways (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- Gamma enolase expression as early marker of neuronal differentiation of murine neuroblastoma cells N-115 (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Spontaneous cytotoxic activity of eosinophilic granule cells separated from the normal peritoneal cavity of Dicentrarchus labrax. (Articolo in rivista) (Prodotto della ricerca)
- Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma. (Articolo in rivista) (Prodotto della ricerca)
- Phosphorylation-dependent regulation of axon fasciculation. (Articolo in rivista) (Prodotto della ricerca)
- Romancino DP., Dalmazio S., Cervello M., Montana G., Virruso L., Bonura A., Gambino R. and Di Carlo M. Localization and association to cytoskeleton of COLL1a mRNA in Paracentrotus lividus egg requires cis- and trans-acting factors (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Spatial distribution of collagene TypeI mRNA in Paracentrotus lividus eggs and embryos. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- IP-deltaEx10-11: a novel splice variant of the apoptosis inhibitor NAIP differently expressed in drug-sensitive and multidrug-resistant HL60 leukemia cells. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Truncated form of beta-catenin and reduced expression of wild-type catenins feature HepG2 human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells. (Articolo in rivista) (Prodotto della ricerca)
- Serum concentration of E-selectin in patients with chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Phosphorylation-dependent regulation of skeletogenesis in sea urchin micromere-derived cells and embryos. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Diverse roles of GSK-3: Tumor promoter-tumor suppressor, target in cancer therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Nanotechnology applications for the therapy of liver fibrosis (Articolo in rivista) (Prodotto della ricerca)
- Multifaceted roles of GSK-3 and Wnt/beta-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- GSK-3 as potential target for therapeutic irvention in cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Heat shock protein 70 serum levels differ significantly in patients with chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Poly (ADP-ribose) polymerase inhibition synergizes with the NF-kB inhibitor DHMEQ to kill hepatocellular carcinoma cells (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Corrigendum to \"Poly (ADP-ribose) polymerase inhibition synergizes with the NF-?B inhibitor DHMEQ to kill hepatocellular carcinoma cells\" [Biochim. Biophys. Acta 1843 (2014) 2662-2673] (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Non invasive tools for the diagnosis of liver cirrhosis (Articolo in rivista) (Prodotto della ricerca)
- Roles of signaling pathways in drug resistance, cancer initiating cells and cancer progression and metastasis (Articolo in rivista) (Prodotto della ricerca)
- Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells. (Articolo in rivista) (Prodotto della ricerca)
- Inhibition of GSK-3 beta activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in breast cancer (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention. (Articolo in rivista) (Prodotto della ricerca)
- Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Suppressing prostate cancer by targeting NGAL (Abstract in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1105)
- Targeting signaling pathways in prostate cancer (Abstract/Comunicazione in rivista) (Prodotto della ricerca)
- GRP78 POLYMORPHISM rs430397 IS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA IN A SOUTHERN ITALIAN POPULATION (Abstract in rivista) (Prodotto della ricerca)
- Development of nimesulide loaded solid lipid nanoparticles. (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Http://www.cnr.it/ontology/persone.owl#argomentoDiRicercaSimile
- Coautore
- Partecipazione di
- Ha afferente
- Responsabile
- Ha pubblicazioni con
- Gestore
- Rapporto con persona
- Http://www.w3.org/2004/02/skos/core#isSubjectOf
